Vote Scores

Home / Companies / TELA Bio, Inc. / 9 Jun 2026

Meeting · year to 30 June 202636 filers reporting

TELA Bio, Inc.: meeting of 9 Jun 2026

Votes reported on Form N-PX, item by item

36 Form N-PX filers reported votes at the TELA Bio, Inc. meeting of 9 Jun 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 75.9% of reported votes for; 5 filers withheld from or voted against at least one nominee.

48 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

49 vote records from 35 filers. 8 of the 32 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.

68.6% for22.9% against8.6% other25.0% against management35 filers73.9% for26.1% against0.0% other26.1% against management25,183,918 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

16 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers100.0% for0.0% against0.0% against management2,162,773 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 9 filers. 2 of the 8 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

66.7% for33.3% against25.0% against management9 filers95.9% for4.1% against4.0% against management2,171,363 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

16 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers96.3% for3.7% against3.7% against management2,162,772 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
State Street and SPDRNo reportForNo report
EquitableForForFor
Northern Trust and FlexSharesNo reportForNo report
BNY MellonNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the TELA Bio, Inc. meeting?

36 Form N-PX filers reported votes at the meeting of 9 Jun 2026. On say-on-pay, 8 of 32 voted against management (25.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by TELA Bio, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for TELA Bio, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing TELA Bio, Inc. with a meeting date within three days of 9 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.